<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://nextoptionresearch.com/blogs/info</loc>
    <lastmod>2026-04-09T20:42:53+01:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/news-articles</loc>
    <lastmod>2026-04-09T20:48:06+01:00</lastmod>
    <changefreq>weekly</changefreq>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/info/how-to-find-clinical-trials-when-standard-treatment-stops-working</loc>
    <lastmod>2026-04-06T14:52:24+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/clinical-trials-blog-hero-image_e307f5a9-d7d1-4218-9e40-d607d46c177f.png?v=1775483544</image:loc>
      <image:title>How to Find Clinical Trials When Standard Treatment Stops Working</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/info/expanded-access-programs-explained-how-to-get-experimental-treatments-legally</loc>
    <lastmod>2026-04-06T15:37:10+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/parent-reviewing-clinical-trial-options_3d314abc-b0b6-4e9c-a764-7db44aeba0c0.png?v=1775486230</image:loc>
      <image:title>Expanded Access Programs Explained: How to Get Experimental Treatments Legally</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/info/personalized-clinical-trial-matching-what-it-is-and-why-independent-research-beats-free-tools</loc>
    <lastmod>2026-04-06T15:13:03+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/two-family-members-reviewing-medical-notes-together_a0e9caed-d73a-4b89-a799-59bdb4d24a72.png?v=1775484783</image:loc>
      <image:title>Personalized Clinical Trial Matching: What It Is and Why Independent Research Beats Free Tools</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/info/compassionate-use-vs-right-to-try-which-pathway-could-work-for-you</loc>
    <lastmod>2026-04-06T15:22:40+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/parent-reviewing-clinical-trial-documents-at-home_22e5a343-cca3-44b2-8680-09cc4c3e2352.png?v=1775485360</image:loc>
      <image:title>Compassionate Use vs Right-to-Try: Which Pathway Could Work for You?</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/news-articles/russia-s-personalized-mrna-cancer-vaccine-enteromix-neoonkovac-what-the-evidence-actually-shows</loc>
    <lastmod>2026-04-06T20:28:39+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/hopeful-medical-consultation-in-modern-clinic.png?v=1775503719</image:loc>
      <image:title>Russia’s Personalized mRNA Cancer Vaccine (Enteromix &amp; Neoonkovac): What the Evidence Actually Shows.</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/news-articles/personalized-mrna-vaccine-shows-multi-year-immunity-in-triple-negative-breast-cancer-tnbc</loc>
    <lastmod>2026-04-06T20:32:35+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/female-oncologist-consulting-with-hopeful-patient.png?v=1775503955</image:loc>
      <image:title>Personalized mRNA Vaccine Shows Multi-Year Immunity in Triple-Negative Breast Cancer (TNBC)</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/news-articles/dipg-in-children-promising-b7-h3-car-t-therapy-results-from-seattle-and-the-first-known-cure-with-everolimus</loc>
    <lastmod>2026-04-06T20:39:40+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/pediatric-neuro-oncologist-reviewing-mri-scans-with-family_4df8c882-6915-4436-9afd-a9e67fe45481.png?v=1775504380</image:loc>
      <image:title>DIPG in Children: Promising B7-H3 CAR-T Therapy Results from Seattle and the First Known Cure with Everolimus</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/news-articles/als-long-term-tofersen-data-for-sod1-als-and-new-gene-therapy-advances</loc>
    <lastmod>2026-04-06T20:46:02+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/als-neurology-consultation-hopeful-empathetic.png?v=1775504762</image:loc>
      <image:title>ALS: Long-Term Tofersen Data for SOD1-ALS and New Gene Therapy Advances</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/news-articles/gene-editing-therapy-delivers-functional-cure-for-severe-sickle-cell-disease-in-new-2026-trial-results</loc>
    <lastmod>2026-04-09T20:31:37+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/couple-in-park-documentary-style.png?v=1775763097</image:loc>
      <image:title>Gene-Editing Therapy Delivers “Functional Cure” for Severe Sickle Cell Disease in New 2026 Trial Results</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/info/off-the-shelf-car-t-therapy-wins-fda-breakthrough-status-for-rare-aggressive-blood-cancers</loc>
    <lastmod>2026-04-09T20:42:53+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/couple-in-hospital-garden-documentary-style.png?v=1775763773</image:loc>
      <image:title>Off-the-Shelf CAR-T Therapy Wins FDA Breakthrough Status for Rare, Aggressive Blood Cancers</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://nextoptionresearch.com/blogs/news-articles/baby-thrives-one-year-after-world-s-first-personalized-crispr-gene-editing-therapy</loc>
    <lastmod>2026-04-09T20:48:06+01:00</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://cdn.shopify.com/s/files/1/1061/2447/6765/articles/toddler-boy-first-steps-in-garden.png?v=1775764086</image:loc>
      <image:title>Baby Thrives One Year After World’s First Personalized CRISPR Gene Editing Therapy</image:title>
    </image:image>
  </url>
</urlset>
